Benjamin Bian
3PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|May 31, 2018
E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments.Wenjun Lan, Benjamin Bian, Yi Xia
|May 19, 2018
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.Gwen Lomberk, Yuna Blum, Rémy Nicolle
|Mar 10, 2017
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts.Benjamin Bian, Martin Bigonnet, Odile Gayet
Pageof 1
Frequent Collaborators
1 joint publications
Nelson Dusetti
1 joint publications
Juan Iovanna
1 joint publications
Gwen Lomberk
1 joint publications
Yuna Blum
1 joint publications
Rémy Nicolle
1 joint publications
Laetitia Marisa
1 joint publications
Zhifu Sun
1 joint publications
Huihuang Yan
1 joint publications
Mira Ayadi
1 joint publications
Tamas Ordog
